Companies › PCVX
VAXCYTE INC (PCVX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001649094 · EDGAR filings · Updated 2026-07-28
VAXCYTE INC (PCVX) has reported institutional ownership of 112.6%, with 334 institutional managers holding positions valued at $9.44B per the latest 13F reporting period.
Filings this week (2)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-27 — Notice of proposed sale filed (Form 144)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-16 — Initial insider ownership filed (Form 3)
- 2026-07-15 — Current report (8-K) filed
- 2026-07-06 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, VAXCYTE INC has 334 institutional holders and institutional ownership of 112.6%.
Insider activity
Insiders reported 70 transactions (0 buys, 8 sells) across 13 reporting insiders, with a net reported value of −$1.70M.
Related companies
CYTOKINETICS INC (CYTK) · DAVITA INC (DVA) · MASIMO CORP (MASI) · GLOBUS MED INC (GMED) · ENCOMPASS HEALTH CORP (EHC) · BIO-TECHNE CORP (TECH)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.